We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Psychosocial Treatment for Attention Deficit Hyperactivity Disorder (ADHD) Type I

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00071656
First Posted: October 30, 2003
Last Update Posted: August 9, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
National Institute of Mental Health (NIMH)
Information provided by:
University of California, San Francisco
October 29, 2003
October 30, 2003
August 9, 2013
September 2002
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT00071656 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Psychosocial Treatment for Attention Deficit Hyperactivity Disorder (ADHD) Type I
Psychosocial Treatment for ADHD Inattentive Type I
The purpose of this study is to develop and implement a treatment that focuses on behaviors to reduce symptom severity and functional impairment in patients with Attention Deficit Hyperactivity Disorder, Predominantly Inattentive Type (ADHD-I). The long-term goal of this study is to apply the treatment to larger-scale trials to determine its effectiveness and generalizability.

ADHD-I is a highly prevalent and serious childhood disorder that affects academic and social development. The symptoms of ADHD-I differ from those of the well-studied ADHD Combined Type. Unfortunately, studies of psychosocial interventions for ADHD-I are currently unavailable. Effective treatments for ADHD-I are still needed.

Participants are randomly assigned to receive either a behavioral intervention or treatment as usual for 10 to 12 weeks. The behavioral intervention includes parent and child skill development groups, family meetings, and consultation with the child's teacher to address attention problems and areas of impairment at home and school. Parent and child interviews, teacher and child ratings, and psychoeducational testing are used to assess participants. Participants are assessed post-treatment and at a 2-month follow-up visit.

Interventional
Not Provided
Allocation: Randomized
Intervention Model: Parallel Assignment
Primary Purpose: Treatment
Attention Deficit Disorder With Hyperactivity
Behavioral: Psychosocial (behavioral) Intervention
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
60
June 2007
Not Provided

Inclusion Criteria:

  • ADHD, Predominantly Inattentive Type
  • Public or private school attendance
  • English speaking
Sexes Eligible for Study: All
7 Years to 11 Years   (Child)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT00071656
R21MH065927( U.S. NIH Grant/Contract )
R21MH065927 ( U.S. NIH Grant/Contract )
DSIR CT-S
Not Provided
Not Provided
Not Provided
Not Provided
University of California, San Francisco
National Institute of Mental Health (NIMH)
Not Provided
University of California, San Francisco
August 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP